ClearPoint Neuro Long Term Debt

ClearPoint Neuro (CLPT) currently reports a long-term debt of $63M as of March 2026. That compares with $2.9M in the prior-year period — up 2115.2% year over year. Use the charts on this page to explore ClearPoint Neuro's long-term debt history and peer comparisons.

ClearPoint Neuro's long-term debt increased from $2.9M to $63M — a 2115.2% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ClearPoint Neuro reported $63M in long-term debt as of March 2026. That compares with $2.9M in the prior-year period — up 2115.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $63M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ClearPoint Neuro, and consider following CLPT for alerts when major investors trade the stock.

ClearPoint Neuro is classified in the Healthcare sector. On long-term debt, it currently shows $63M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLPT with unrelated industries.